Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a bid to end...
Biocon Biologics Ltd., a subsidiary of Bengaluru-headquartered Biocon Ltd., has announced that Kixelle, a biosimilar insulin as part co-developed with NASDAQ-listed Viatris Inc., has received...
BENGALURU: The government’s proposals for the healthcare sector in the Union Budget 2021-22 would encourage more research and development (R&D), while an allocation of Rs.35000...
Bengaluru: Biocon founder Kiran Mazumdar-Shaw on Tuesday sought quick processing of regulatory approvals in India for the AstraZeneca-Oxford vaccine after regulators in the UK cleared...
Bengaluru: Biocon founder Kiran Mazumdar-Shaw on Tuesday sought quick processing of regulatory approvals in India for the AstraZeneca-Oxford vaccine after regulators in the UK cleared...
Mumbai: Nearly seven years after the country enacted a law to prevent harassment of women at workplaces, several Indian companies still seem to be fumbling...
BENGALURU: Biopharmaceuticals company Biocon Ltd has announced that Anupam Jindal has been appointed as its new Chief Financial Officer. Prior to joining the Bengaluru-headquartered company,...
After years of manufacturing woes torpedoed their chances to challenge Sanofi’s blockbuster insulin injection Lantus, Mylan and Biocon recently received the FDA’s go-ahead to launch...
We are very excited that we have finally crossed the finishing line and we are now launching, says Executive Chairman, Biocon.You have launched glargine in...